Microplate Dx Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 15

Employees

  • Latest Deal Type
  • Series A
  • (Upcoming)

  • Latest Deal Amount
  • $13.3M

  • Investors
  • 17

Microplate Dx General Information

Description

Developer of rapid diagnostic technologies designed to detect antimicrobial resistance and guide antibiotic treatment decisions. The company offers rapid antibiotic susceptibility testing, infectious disease diagnostics, point-of-care testing solutions, biosensor-based diagnostic platforms, and antimicrobial stewardship tools, enabling clinicians to identify effective antibiotics and treat infections more quickly and accurately.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Royal College Building, 204 George Street
  • Suite 534
  • Glasgow G1 1XW
  • Scotland, United Kingdom
+44 0141
Primary Industry
Diagnostic Equipment
Corporate Office
  • Royal College Building, 204 George Street
  • Suite 534
  • Glasgow G1 1XW
  • Scotland, United Kingdom
+44 0141

Microplate Dx Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Microplate Dx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
19. Early Stage VC (Series A) $13.3M Upcoming Product In Beta Test
18. Accelerator/Incubator 23-Mar-2026 Completed Startup
17. Early Stage VC 08-Sep-2025 Completed Product In Beta Test
16. Accelerator/Incubator 06-Jun-2025 Completed Product In Beta Test
15. Grant 06-Feb-2025 Completed Product In Beta Test
14. Grant 01-Dec-2024 Completed Product In Beta Test
13. Grant Completed Product In Beta Test
12. Early Stage VC 01-Feb-2024 Completed Product In Beta Test
11. Secondary Transaction - Private $3.8M Completed Product In Beta Test
10. Seed Round 11-Sep-2023 $3.16M $3.8M Completed Product In Beta Test
To view Microplate Dx’s complete valuation and funding history, request access »

Microplate Dx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary Shares
Ordinary Shares
To view Microplate Dx’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Microplate Dx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of rapid diagnostic technologies designed to detect antimicrobial resistance and guide antibiotic treatment de
Diagnostic Equipment
Glasgow, United Kingdom
15 As of 2025

Sydney, Australia
 

Bristol, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Microplate Dx Competitors (5)

One of Microplate Dx’s 5 competitors is SpeeDx, a Venture Capital-Backed company based in Sydney, Australia.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
SpeeDx Venture Capital-Backed Sydney, Australia
FluoretiQ Venture Capital-Backed Bristol, United Kingdom
DeepUll Venture Capital-Backed Barcelona, Spain
iFAST Venture Capital-Backed Fareham, United Kingdom
Sysmex Astrego Formerly VC-backed Uppsala, Sweden
You’re viewing 5 of 5 competitors. Get the full list »

Microplate Dx Patents

Microplate Dx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202416505-D0 A method and system for identifying microbes Pending 08-Nov-2024
GB-2702578-A A method and system for identifying microbes Pending 08-Nov-2024
WO-2026099465-A1 A method and system for identifying microbes Pending 08-Nov-2024
EP-4713472-A1 A system for identifying microbial growth Pending 16-May-2023
GB-202307287-D0 A system for identifying microbial growth Active 16-May-2023 C12M1/3407
To view Microplate Dx’s complete patent history, request access »

Microplate Dx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Microplate Dx Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
Future4care Accelerator/Incubator
MedTech Innovator Accelerator/Incubator
SBRI Healthcare Government
National Institute for Health Research Invention for Innovation Government
Impact Venture Family Office Minority
You’re viewing 5 of 17 investors. Get the full list »

Microplate Dx FAQs

  • When was Microplate Dx founded?

    Microplate Dx was founded in 2021.

  • Where is Microplate Dx headquartered?

    Microplate Dx is headquartered in Glasgow, United Kingdom.

  • What is the size of Microplate Dx?

    Microplate Dx has 15 total employees.

  • What industry is Microplate Dx in?

    Microplate Dx’s primary industry is Diagnostic Equipment.

  • Is Microplate Dx a private or public company?

    Microplate Dx is a Private company.

  • What is Microplate Dx’s current revenue?

    The current revenue for Microplate Dx is .

  • How much funding has Microplate Dx raised over time?

    Microplate Dx has raised $14.3M.

  • Who are Microplate Dx’s investors?

    Future4care, MedTech Innovator, SBRI Healthcare, National Institute for Health Research Invention for Innovation, and Impact Venture are 5 of 17 investors who have invested in Microplate Dx.

  • Who are Microplate Dx’s competitors?

    SpeeDx, FluoretiQ, DeepUll, iFAST, and Sysmex Astrego are competitors of Microplate Dx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process